Dickerson, Jr. and Lou, “Micro-quantitation of lens myo-inositol by anion exchange chromatography,” Curr. Eye Res., 9(2):201-205, 1990. |
Montanaro et al., “A metalloproteinase associated with gelonin, a ribosome inactivating protein,” Ital. J. Biochem, pp. 1-10, 1985. |
Toy, “The Inerferons”, Clin. Exp. Immunol., 54:1-13, 1983. |
Stirpe et al., “Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells,” J. Biol. Chem., 255 (14):6947-6953, 1980. |
Young and Davis, “Yeast RNA polymerase II genes: Isolation with antibody probes,” Science, 222:778-782, 1983. |
Sivam et al., “Immunotoxins to a human melanoma-associated antigen: Comparison of gelonin with ricin and other A chain conjugates,” Cancer Res., 47:3169-3173, 1987. |
Falasca et al., “Properties of the ribosome-inactivating proteins gelonin, momordica charantia inhibitor, and dianthins,” Biochem. J., 207:505-509, 1982. |
Jacobs et al., “Isolation and characterization of genomic and cDNA clones of human erythropoietin,” Nature, 313:806-810, 1985. |
Watanabe et al., “Selection of chromatographic protein purification operations based on physicochemical properties,” Annals New York Academy of Science, 348-359, 1994. |
Roselli et al., “Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts,” J. Nucl. Med., 30:672-682, 1989. |
Lambert et al., “Immunotoxins containing single-chain ribosome-inactivating proteins, ABSTRACt,” Cancer Treat. Res., 37:175-209, 1988. |
Ronneberger, “Toxicological testing of monoclonal antibodies,” ABSTRACT, Dev. Biol. Stand., 71:185-90, 1990. |
Edwards et al., “A simple and rapid method method for the preparation of plant genomic DNA for PCR analysis,” Nucleic Acids Research, 19(6):1349, 1991. |
Dunbar, “Purification of proteins from polyacrylamide gels,” In: Two-dimensional electrophoresis and immunological techniques, Plenum Press, New York and London, pp. 32-34, 1987. |
Sperti et al., “Interaction of gelonin with zinc.” Ital. J. Biochem., 35(4):266-271, 1986. |
Montecucchi et al., “N-terminal sequence of some ribosome-inactivating proteins,” Int. J. Peptide Protein Res., 33:263-267, 1989. |
Young and Davis, “Efficient isolation of genes by using antibody probes,” Proc. Natl. Acad. Sci. USA, 80:1194-1198, 1983. |
Collins et al., “Primary amino acid sequence of α-trichosanthin and molecular models for abrin a-chain and α-trichosanthin,” J. Biol. Chem., 265(15):8665-8669, 1990. |
Pastan et al., “Immunotoxins,” Cell, 47:641-646, 1986. |
Descotes et al., “The immunological activity of plant toxins used in the preparation of immunotoxins-II. The immunodepressive activity of gelonin,” Int. J. Immunopharmac., 7(4):455-463, 1985. |
Srinivasan et al., “Chemical modification studies of gelonin,”FEBS, 192(1):113-118, 1985. |
Lambert et al., “Purified immunotoxins that are reactive with human lymphoid cells,” J. Biol.Chem., 260(22):12035-12041, 1985. |
Knowles and Thorpe, “Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B,” Analytical Biochem., 160:440-443, 1987. |
Myers and Villemez, “Specific chemical cleavage of diphtheria toxin with hydroxylamine,” The J. of Biol. Chem., 263(32):17122-17127, 1988. |
Kusui et al., “cDNA cloning and expression of bauhinia purpurea lectin,” J. Biochem., 109:899-903, 1991. |
Hertler and Frankel, “Immunotoxins: a clinical review of their use in the treatment of malignancies,” J. Clin. Oncology, 7(12):1932-1942, 1989. |
Spooner and Lord, “Expression of antibody-ricin A chain fusions in mammalian cells,” In: Applications in clinical oncology, Agamemnon Epenetos (Ed.), pp. 65-77, 1994. |
Maxwell et al., “Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer call suicide,” Cancer Research, 46(9):4660-4664, 1986. |
Harrison et al., “Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an hiv-regulated diphtheria toxin A chain gene,” Human Gene Therapy, 3:461-469, 1992. |
Ogata et al., “Cell-mediated cleavage of pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol,” J. Biolog. Chem., 267(35):25396-25401, 1992. |
Debinski and Pastan, “Monovalent immunotoxin containing truncated form of pseudomonas exotoxin as potent antitumor agent,” Cancer Res., 52:5379-5385, 1992. |
Palmiter et al., “Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene,” Cell, 50:435-443, 1987. |
Zamboni et al., “High-pressure-liquid-chromatographic and fluorimetric methods for the determination of adenine released from ribosomes by ricin and gelonin”, Biochem. J., 259:639-643, 1989. |
Theuer et al., “A recombinant form of pseudomonas exotoxin directed at epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing,” Jour, Biological C., 267(24):16872-16877, 1992. |
Benoit et al., Curr. Eye Res., vol. 9 Suppl., 1990, pp. 201-205. |